Trials / Unknown
UnknownNCT02180451
Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- Vanda Pharmaceuticals · Industry
- Sex
- All
- Age
- 6 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterize the circadian rhythm disruption experienced by patients as determined by plasma melatonin, cortisol, and other circadian analytes
Conditions
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2014-07-02
- Last updated
- 2016-03-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02180451. Inclusion in this directory is not an endorsement.